Mr. Speaker, the end objective is to protect Canadians and ensure their safety. All instruments and regulatory mechanisms are or should be designed to achieve that end, first and foremost. There is not a member in the House who would sacrifice that objective and principle on a wing and a prayer. I think that is why the legislation has been brought forward.
There are some gaps in the Food and Drugs Act, going back to 1953, that need to be updated. At the end of the day when the bill comes out of committee, and I am sure that all members in the House would agree, if Canadians cannot be assured that their safety has been protected and is characterized in the legislation, then we would be placing Canadians at serious risk and would have to oppose that legislation.
As I said and will say to my colleague, I am very optimistic, having heard the quality of this debate, that what comes out of committee will satisfy the broad spectrum of Canadians and the broad spectrum of interests within the natural products area.